Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
BMI1081
IHC control array containing 4 cases of strong, moderate, weak/nil BMI-1 expressers in duplicates
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$54
1 slide
In-Stock
A | |
B | |
C | |
D | |


TNM Classification: Lung carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed or tumor proven by the presence of malignant cell in sputum or bronchial washing but not visualized by imaging of bronchoscopy;
TO - No evidence of primary tumor;
Tis- Carcinoma in situ;
T1 - Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than lobular bronchus;
T2 - Tumor with any of the following features of size or extent; more than 3 cm in greatest dimension; involves main bronchus, 2 cm more proximal to carina; invades visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but not involve the entire lung;
T3 - Tumor of any size that directly invades any of the followings: chest wall (including superior sulcus tumor), diaphragm, mediastinal pleura, parietal pericardium; tumors in the main bronchus less than 3 cm distal to the carina; associated with atelectasis or obstructive pneumonitis of entire lung;
T4 - Tumor of any size that invades any of the following: mediastinum, heart, great vessel, trachea, esophagus, vertebral body, carina, separate tumor nodule(s) in the same,lobe; tumor with malignant pleural effusion.
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed;
NO - No regional lymph node metastasis;
N1 - Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension;
N2 - Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes;
N3 - Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral, scalene, or supraclavicular lymph nodes.
M - Distant metastasis
MX - Distant metastasis cannot be assessed MO - No distant metastasis;
M1 - Distant metastasis, including separate tumor nodule(s) in a different lobe (ipsilateral or contralateral).
Human
4
8
1.5mm
4um
4
2
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
QA/QC control for IHC or ISH detection of BMI-1 protein or RNA molecule in human tissues.

ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 45 | Lung | Small cell carcinoma | T2N0M0 | ||
A02 | F | 45 | Lung | Small cell carcinoma | T2N0M0 | ||
B01 | M | 59 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
B02 | M | 59 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
C01 | M | 73 | Lung | Small cell carcinoma | T2N0M0 | ||
C02 | M | 73 | Lung | Small cell carcinoma | T2N0M0 | ||
D01 | F | 67 | Liver | Normal | |||
D02 | F | 67 | Liver | Normal | |||
null |